Operating Expenses Summary of Aspen Pharmacare Holdings Limited

Aspen Pharmacare Holdings Limited's latest annual operating expenses in 2023 was 12.41 Billion ZAR , up 11.47% from previous year.
Aspen Pharmacare Holdings Limited's latest quarterly operating expenses in 2023 Q2 was 5.81 Billion ZAR , up 98.5% from previous quarter.
Aspen Pharmacare Holdings Limited reported a annual operating expenses of 9.46 Billion ZAR in annual operating expenses 2022, down -0.03% from previous year.
Aspen Pharmacare Holdings Limited reported a annual operating expenses of 9.46 Billion ZAR in annual operating expenses 2021, up 10.13% from previous year.
Aspen Pharmacare Holdings Limited reported a quarterly operating expenses of 6.6 Billion ZAR for 2023 Q4, down 0.0% from previous quarter.
Aspen Pharmacare Holdings Limited reported a quarterly operating expenses of 2.92 Billion ZAR for 2023 Q1, down -39.06% from previous quarter.

Annual Operating Expenses Chart of Aspen Pharmacare Holdings Limited (2023 - 2002)

Historical Annual Operating Expenses of Aspen Pharmacare Holdings Limited (2023 - 2002)

Year	Operating Expenses	Operating Expenses Growth
2023	12.41 Billion ZAR	11.47%
2022	9.46 Billion ZAR	-0.03%
2021	9.46 Billion ZAR	10.13%
2020	8.59 Billion ZAR	-17.09%
2019	10.36 Billion ZAR	0.36%
2018	10.33 Billion ZAR	-6.34%
2017	11.03 Billion ZAR	-4.91%
2016	11.6 Billion ZAR	30.34%
2015	8.9 Billion ZAR	1.09%
2014	8.8 Billion ZAR	39.82%
2013	6.29 Billion ZAR	50.38%
2012	4.18 Billion ZAR	25.53%
2011	3.33 Billion ZAR	35.35%
2010	2.46 Billion ZAR	23.88%
2009	1.98 Billion ZAR	16.8%
2008	1.7 Billion ZAR	72.01%
2007	990.16 Million ZAR	14.47%
2006	865.01 Million ZAR	25.01%
2005	691.93 Million ZAR	9.31%
2004	633 Million ZAR	25.51%
2003	504.34 Million ZAR	21.83%
2002	413.98 Million ZAR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2023 Q2	5.81 Billion ZAR	98.5%
2023 Q4	6.6 Billion ZAR	0.0%
2023 Q1	2.92 Billion ZAR	-39.06%
2022 Q4	4.8 Billion ZAR	55.58%
2022 Q1	2.65 Billion ZAR	-37.63%
2022 Q2	4.62 Billion ZAR	74.25%
2022 Q3	3.08 Billion ZAR	-33.16%
2022 FY	9.46 Billion ZAR	-0.03%
2021 Q1	2.39 Billion ZAR	-45.14%
2021 FY	9.46 Billion ZAR	10.13%
2021 Q2	4.28 Billion ZAR	79.22%
2021 Q3	2.3 Billion ZAR	-46.19%
2021 Q4	4.25 Billion ZAR	84.31%
2020 FY	8.59 Billion ZAR	-17.09%
2020 Q3	2.45 Billion ZAR	-41.05%
2020 Q2	4.16 Billion ZAR	44.31%
2020 Q1	2.88 Billion ZAR	-34.73%
2020 Q4	4.36 Billion ZAR	77.49%
2019 Q3	3.26 Billion ZAR	-27.18%
2019 FY	10.36 Billion ZAR	0.36%
2019 Q4	4.42 Billion ZAR	35.71%
2019 Q1	2.66 Billion ZAR	-45.17%
2019 Q2	4.47 Billion ZAR	68.02%
2018 Q2	2.78 Billion ZAR	0.0%
2018 FY	10.33 Billion ZAR	-6.34%
2018 Q4	4.86 Billion ZAR	6.94%
2018 Q3	4.54 Billion ZAR	63.0%
2018 Q1	2.78 Billion ZAR	-3.66%
2017 Q3	2.89 Billion ZAR	13.05%
2017 Q1	2.56 Billion ZAR	-22.97%
2017 FY	11.03 Billion ZAR	-4.91%
2017 Q4	2.89 Billion ZAR	0.0%
2017 Q2	2.56 Billion ZAR	0.0%
2016 Q2	2.5 Billion ZAR	0.0%
2016 FY	11.6 Billion ZAR	30.34%
2016 Q4	3.32 Billion ZAR	0.0%
2016 Q3	3.32 Billion ZAR	32.94%
2016 Q1	2.5 Billion ZAR	-21.88%
2015 Q3	3.2 Billion ZAR	88.24%
2015 Q4	3.2 Billion ZAR	0.0%
2015 FY	8.9 Billion ZAR	1.09%
2015 Q1	1.7 Billion ZAR	-25.05%
2015 Q2	1.7 Billion ZAR	0.0%
2014 Q1	2.28 Billion ZAR	37.4%
2014 FY	8.8 Billion ZAR	39.82%
2014 Q4	2.26 Billion ZAR	0.0%
2014 Q3	2.26 Billion ZAR	-0.59%
2014 Q2	2.28 Billion ZAR	0.0%
2013 FY	6.29 Billion ZAR	50.38%
2013 Q4	1.66 Billion ZAR	0.0%
2013 Q3	1.66 Billion ZAR	21.21%
2013 Q2	1.37 Billion ZAR	0.0%
2013 Q1	1.37 Billion ZAR	20.46%
2012 Q1	934.75 Million ZAR	212.09%
2012 Q3	1.13 Billion ZAR	21.67%
2012 FY	4.18 Billion ZAR	25.53%
2012 Q4	1.13 Billion ZAR	0.0%
2012 Q2	934.75 Million ZAR	0.0%
2011 Q3	-833.92 Million ZAR	-35.35%
2011 Q1	-616.12 Million ZAR	0.0%
2011 Q4	-833.92 Million ZAR	0.0%
2011 Q2	-616.12 Million ZAR	0.0%
2011 FY	3.33 Billion ZAR	35.35%
2010 Q4	-616.12 Million ZAR	0.0%
2010 Q2	-497.35 Million ZAR	0.0%
2010 FY	2.46 Billion ZAR	23.88%
2010 Q3	-616.12 Million ZAR	-23.88%
2010 Q1	-497.35 Million ZAR	0.0%
2009 Q3	-497.35 Million ZAR	-16.8%
2009 FY	1.98 Billion ZAR	16.8%
2009 Q1	-425.8 Million ZAR	0.0%
2009 Q4	-497.35 Million ZAR	0.0%
2009 Q2	-425.8 Million ZAR	0.0%
2008 FY	1.7 Billion ZAR	72.01%
2008 Q4	-425.8 Million ZAR	0.0%
2008 Q3	-425.8 Million ZAR	-72.01%
2008 Q2	-247.54 Million ZAR	0.0%
2008 Q1	-247.54 Million ZAR	0.0%
2007 Q1	-216.25 Million ZAR	0.0%
2007 Q2	-216.25 Million ZAR	0.0%
2007 Q3	-247.54 Million ZAR	-14.47%
2007 FY	990.16 Million ZAR	14.47%
2007 Q4	-247.54 Million ZAR	0.0%
2006 Q3	-216.25 Million ZAR	-247.81%
2006 Q2	146.3 Million ZAR	0.0%
2006 Q1	146.3 Million ZAR	0.0%
2006 Q4	-216.25 Million ZAR	0.0%
2006 FY	865.01 Million ZAR	25.01%
2005 Q1	138.76 Million ZAR	0.0%
2005 FY	691.93 Million ZAR	9.31%
2005 Q3	146.3 Million ZAR	5.44%
2005 Q4	146.3 Million ZAR	0.0%
2005 Q2	138.76 Million ZAR	0.0%
2004 Q1	247.32 Million ZAR	0.0%
2004 FY	633 Million ZAR	25.51%
2004 Q3	138.76 Million ZAR	-43.9%
2004 Q4	138.76 Million ZAR	0.0%
2004 Q2	247.32 Million ZAR	0.0%
2003 Q2	-103.49 Million ZAR	0.0%
2003 Q4	247.32 Million ZAR	0.0%
2003 Q3	247.32 Million ZAR	338.97%
2003 FY	504.34 Million ZAR	21.83%
2003 Q1	-103.49 Million ZAR	0.0%
2002 FY	413.98 Million ZAR	0.0%
2002 Q4	-103.49 Million ZAR	0.0%
2002 Q3	-103.49 Million ZAR	0.0%

Peer Operating Expenses Comparison of Aspen Pharmacare Holdings Limited

Name	Operating Expenses	Operating Expenses Difference

Global Stocks Search

Aspen Pharmacare Holdings Limited (APN.JO)

Operating Expenses Summary of Aspen Pharmacare Holdings Limited

Annual Operating Expenses Chart of Aspen Pharmacare Holdings Limited (2023 - 2002)

Historical Annual Operating Expenses of Aspen Pharmacare Holdings Limited (2023 - 2002)

Peer Operating Expenses Comparison of Aspen Pharmacare Holdings Limited